Suppr超能文献

抗抑郁药敏感性5-羟色胺转运体的磷酸化与调控

Phosphorylation and regulation of antidepressant-sensitive serotonin transporters.

作者信息

Ramamoorthy S, Giovanetti E, Qian Y, Blakely R D

机构信息

Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-6600, USA.

出版信息

J Biol Chem. 1998 Jan 23;273(4):2458-66. doi: 10.1074/jbc.273.4.2458.

Abstract

Antidepressant-sensitive serotonin (5-hydroxytryptamine, 5HT) transporters (SERTs) are responsible for efficient synaptic clearance of extracellular 5HT. Previously (Qian, Y., Galli, A., Ramamoorthy, S., Risso, S., DeFelice, L. J., and Blakely, R. D. (1997) J. Neurosci. 17, 45-47), we demonstrated that protein kinase (PKC)-linked pathways in transfected HEK-293 cells lead to the internalization of cell-surface human (h) SERT protein and a reduction in 5HT uptake capacity. In the present study, we report that PKC activators rapidly, and in a concentration-dependent manner, elevate the basal level of hSERT phosphorylation 5-6-fold. Similarly, protein phosphatase (PP1/PP2A) inhibitors down-regulate 5HT transport and significantly elevate hSERT 32P incorporation, effects that are additive with those of PKC activators. Moreover, hSERT phosphorylation induced by beta-phorbol 12-myristate 13-acetate is abolished selectively by the PKC inhibitors staurosporine and bisindolylmaleimide I, whereas hSERT phosphorylation induced by phosphatase inhibitors is insensitive to these agents at comparable concentrations. Protein kinase A and protein kinase G activators fail to acutely down-regulate 5HT uptake but significantly enhance hSERT phosphorylation. Basal hSERT and okadaic acid-induced phosphorylation were insensitive to chelation of intracellular calcium and Ca2+/calmodulin-dependent protein kinase inhibitors. Together these results reveal hSERT to be a phosphoprotein whose phosphorylation state is likely to be tightly controlled by multiple kinase and phosphatase pathways that may also influence the transporter's regulated trafficking.

摘要

对抗抑郁药敏感的血清素(5-羟色胺,5HT)转运体(SERTs)负责细胞外5HT的高效突触清除。此前(钱,Y.,加利,A.,拉马穆尔蒂,S.,里索,S.,德费利切,L. J.,和布莱克利,R. D.(1997年)《神经科学杂志》17卷,45 - 47页),我们证明转染的HEK - 293细胞中与蛋白激酶(PKC)相关的信号通路会导致细胞表面人(h)SERT蛋白内化,并降低5HT摄取能力。在本研究中,我们报告PKC激活剂能迅速且以浓度依赖的方式将hSERT磷酸化的基础水平提高5 - 6倍。同样,蛋白磷酸酶(PP1/PP2A)抑制剂会下调5HT转运,并显著提高hSERT的32P掺入量,这些效应与PKC激活剂的效应相加。此外,β-佛波醇12 - 肉豆蔻酸13 - 乙酸酯诱导的hSERT磷酸化被PKC抑制剂星形孢菌素和双吲哚马来酰亚胺I选择性消除,而磷酸酶抑制剂诱导的hSERT磷酸化在相当浓度下对这些药物不敏感。蛋白激酶A和蛋白激酶G激活剂不能急性下调5HT摄取,但能显著增强hSERT磷酸化。基础hSERT和冈田酸诱导的磷酸化对细胞内钙螯合及Ca2 +/钙调蛋白依赖性蛋白激酶抑制剂不敏感。这些结果共同表明hSERT是一种磷蛋白,其磷酸化状态可能受到多种激酶和磷酸酶信号通路的严格控制,这些信号通路也可能影响转运体的调节性转运。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验